Beta-arrestin 2 modulates resveratrol-induced apoptosis and regulation of Akt/GSK3β pathways

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 9, 2010, Pages 912-918

  Sun, Xiuli ^a,b   Zhang, Yi ^b   Wang, Jianliu ^a   Wei, Lihui ^a   Li, Hui ^b   Hanley, Gregory ^b   Zhao, Miaoqing ^b   Li, Yi ^b   Yin, Deling ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b East Tennessee State University   (United States)

Author keywords

Akt; Apoptosis; Endometrial cancer; GSK3 ; Resveratrol; Arrestin 2

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; RESVERATROL; ANTINEOPLASTIC AGENT; BETA ARRESTIN; CASP3 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; RETINA S ANTIGEN; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; DRUG EFFECTS; ENDOMETRIAL NEOPLASMS; GENETICS; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ARRESTINS; CASPASE 3; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; ENZYME ACTIVATION; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STILBENES;

EID: 77955271629     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2010.04.015     Document Type: Article

References (42)

1. Krupnick J.G., Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 1998, 38:289-319.
2. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308:512-517.
3. Lohse M.J., Benovic J.L., Codina J., Caron M.G., Lefkowitz R.J. Beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 1990, 248:1547-1550.
4. Attramadal H., Arriza J.L., Aoki C., Dawson T.M., Codina J., Kwatra M.M., Snyder S.H., Caron M.G., Lefkowitz R.J. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J. Biol. Chem. 1992, 267:17882-17890.
5. Fong A.M., Premont R.T., Richardson R.M., Yu Y.R., Lefkowitz R.J., Patel D.D. Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:7478-7483.
6. Parruti G., Lombardi M.S., Chuang T.T., De Blasi A. Rhodopsin phosphorylation by transiently expressed human beta ARK1: a new method for drug development. J. Recept. Res. 1993, 13:95-103.
7. Cen B., Yu Q., Guo J., Wu Y., Ling K., Cheng Z., Ma L., Pei G. Direct binding of beta-arrestins to two distinct intracellular domains of the delta opioid receptor. J. Neurochem. 2001, 76:1887-1894.
8. Perry S.J., Lefkowitz R.J. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol. 2002, 12:130-138.
9. DeFea K.A., Zalevsky J., Thoma M.S., Dery O., Mullins R.D., Bunnett N.W. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 2000, 148:1267-1281.
10. Revankar C.M., Vines C.M., Cimino D.F., Prossnitz E.R. Arrestins block G protein-coupled receptor-mediated apoptosis. J. Biol. Chem. 2004, 279:24578-24584.
11. Povsic T.J., Kohout T.A., Lefkowitz R.J. Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J. Biol. Chem. 2003, 278:51334-51339.
12. Wang Y., Tang Y., Teng L., Wu Y., Zhao X., Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 2006, 7:139-147.
13. Li Y., Sun X.L., Zhang Y., Huang J.J., Hanley G., Ferslew K.E., Peng Y., Yin D.L. Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2. Biochem. Biophys. Res. Commun. 2009, 378:857-861.
14. Temkin S.M., Fleming G. Current treatment of metastatic endometrial cancer. Cancer Control. 2009, 16:38-45.
15. Pennant S., Manek S., Kehoe S. Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review. J. Obstet. Gynaecol. 2008, 28:632-633.
16. Sexton E., Van Themsche C., LeBlanc K., Parent S., Lemoine P., Asselin E. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol. Cancer 2006, 5:45.
17. Filomeni G., Graziani I., Rotilio G., Ciriolo M.R. Trans-resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr. 2007, 2:295-305.
18. Pozo-Guisado E., Alvarez-Barrientos A., Mulero-Navarro S., Santiago-Josefat B., Fernandez-Salguero P.M. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol. 2002, 64:1375-1386.
19. Hudson T.S., Hartle D.K., Hursting S.D., Nunez N.P., Wang T.T., Young H.A., Arany P., Green J.E. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res. 2007, 67:8396-8405.
20. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 2004, 29:95-102.
21. Martin M., Rehani K., Jope R.S., et al. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol 2005, 6:777-784.
22. Woodgett J.R., Ohashi P.S. GSK3: an in-Toll-erant protein kinase?. Nat. Immunol. 2005, 6:751-752.
23. Beurel E., Jope R.S. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 2006, 79:173-189.
24. Beaulieu J.M., Gainetdinov R.R., Caron M.G. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 2007, 28:166-172.
25. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005, 122:261-273.
26. Horne A.W., Lalani E.N., Margara R.A. The effects of sex steroid hormones and interleukin-1-beta on MUC1 expression in endometrial epithelial cell lines. Reproduction 2006, 131:733-742.
27. Mo B., Vendrov A.E., Palomino W.A., DuPont B.R., Apparao K.B., Lessey B.A. The effects of sex steroid hormones and interleukin-1-beta on MUC1 expression in endometrial epithelial cell lines. Biol. Reprod. 2006, 75:387-394.
28. Wang P., Gao H., Ni Y., Wang B., Wu Y., Ji L., Qin L., Ma L., Pei G. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J. Biol. Chem. 2003, 278:6363-6370.
29. Yin D.L., Tuthill D., Mufson R.A., Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J. Exp. Med. 2000, 191:1423-1428.
30. Zhang Y., Foster R., Sun X.L., Yin Q.Q., Li Y., Hanley G., Stuart C., Gan Y., Li C., Zhang Z., Yin D.L. Restraint stress induces lymphocyte reduction through p53 and PI3K/NF-kappaB pathways. J. Neuroimmunol. 2008, 200:71-76.
31. Yin D.L., Woodruff M., Zhang Y., Whaley S., Miao J., Ferslew K., Zhao J., Stuart C. Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/AKT/NF-kappaB pathways. J. Neuroimmunol. 2006, 174:101-107.
32. Thorburn A. Death receptor-induced cell killing. Cell Signal. 2004, 16:139-144.
33. Moore C.A., Milano S.K., Benovic J.L. Regulation of receptor trafficking by GRKs and arrestins. Annu. Rev. Physiol. 2007, 69:451-482.
34. Buchanan F.G., DuBois R.N. Emerging roles of beta-arrestins. Cell Cycle 2006, 5:2060-2063.
35. De Ruvo C., Amodio R., Algeri S., Martelli N., Intilangelo A., D'Ancona G.M., Esposito E. Nutritional antioxidants as antidegenerative agents. Int. J. Dev. Neurosci. 2000, 18:359-366.
36. Tseng S.H., Lin S.M., Chen J.C., Su Y.H., Huang H.Y., Chen C.K., Lin P.Y., Chen Y. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin. Cancer Res. 2004, 10:2190-2202.
37. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
38. Bowers J.L., Tyulmenkov V.V., Jernigan S.C., Klinge C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000, 141:3657-3667.
39. Prodi G., De Giovanni C., Galli M.C., Gola G., Grilli S., Rocchetta R., Orlandi C. 17 beta-estradiol, 5 alpha-dihydrotestosterone, progesterone and cortisol receptors in normal and neoplastic human endometrium. Tumori 1979, 65:241-253.
40. Ramadori G., Zohrens G., Manns M., Rieder H., Dienes H.P., Hess G., Meyer K.H., Buschenfelde Z. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur. J. Clin. Invest. 1991, 21:323-330.
41. Eldadah B.A., Faden A.I. Caspase pathways, neuronal apoptosis, and CNS injury. J. Neurotrauma 2000, 17:811-829.
42. Zhang Y., Zhang Y., Miao J., Hanley G., Stuart C., Sun X.L., Chen T.T., Yin D.L. Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling. J. Neuroimmunol. 2008, 204:13-19.